Scientific understanding continues to develop as additional controlled laboratory and preclinical studies emerge
Unit Count 60 Warnings Keep your licensed health care practitioner informed when using this product
The most significant clinical data for retatrutide to date comes from a Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023)
Excluded are defendants, the company's officers and directors at all relevant times, their immediate families, legal representatives, heirs, successors or assigns, and any entity in which defendants have or had a controlling interest
synthesized PEGylated artesunate precursor drug (mPEG-ART) and found that the precursor drug ameliorated LPS-induced acute lung injury, suggesting its potential use as an anti-inflammatory agent (Hao et al., 2022)
First, administering two separate injections increases discomfort, infection risk, and injection site reactions compared to a single well-placed shot